New UK Vision Strategy launched

Article

The refreshed UK Vision Strategy was launched at the Vision UK 2013 Conference, according to a press statement.

The refreshed UK Vision Strategy was launched at the Vision UK 2013 Conference.

The strategy, held at the QE2 Centre, London, UK, contains all the aims of the original 2008 strategy but has undergone significant development. Three new key outcomes of the measure were announced including the encouragement of the UK population to maintain their eyesight, guaranteeing primary treatment for those with existing eye conditions and ensuring those with sight loss can fully participate in society.

Don Grocott, Optical Confederation Chairman, commented, “Much has been achieved under the original UK Vision Strategy, not least the Eye Health Indicator in England and the considerable work to improve eye health, prevent visual impairment and enable people with sight loss to lead active, full and inclusive lives in all four UK countries.”

“However, there is much more to do and people in this country, especially older people and people from minority groups, are still losing their sight at rates which are just not acceptable,” continued Mr Grocott. “As founder members of the UK Vision Strategy and enthusiastic supporters of Vision 2020 UK, the Optical Confederation and its members will continue to strive to improve eye health for all and offer access to the highest quality community eye health services and vision correction.”

David Hewlett, representing the Optical Confederation at the conference, stated, “Continuing emphasis on the importance of looking after your eyes and regular sight testing is very welcome. This is the best means of achieving eye health for all and reducing the unacceptable levels of avoidable sight loss in the UK.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.